Kayne Anderson Rudnick Investment Management LLC Gsk PLC Transaction History

Kayne Anderson Rudnick Investment Management LLC

$43.7 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$42.05 - $47.77 $4,078 - $4,633	97 Added 0.4%	24,517 $1.07 Million
Q1 2022 May 16, 2022	SELL	$40.23 - $47.74 $18,747 - $22,246	-466 Reduced 1.87%	24,420 $1.06 Million
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $5,404 - $6,298	-139 Reduced 0.56%	24,886 $1.1 Million
Q3 2021 Nov 12, 2021	BUY	$38.79 - $43.16 $26,532 - $29,521	684 Added 2.81%	25,025 $956,000
Q2 2021 Aug 13, 2021	SELL	$36.52 - $41.46 $53,611 - $60,863	-1,468 Reduced 5.69%	24,341 $969,000
Q1 2021 May 17, 2021	SELL	$34.27 - $40.01 $10.9 Million - $12.8 Million	-319,092 Reduced 92.52%	25,809 $921,000
Q4 2020 Feb 12, 2021	SELL	$34.07 - $39.94 $1.48 Million - $1.74 Million	-43,494 Reduced 11.2%	344,901 $12.7 Million
Q3 2020 Nov 16, 2020	BUY	$38.11 - $42.99 $6.94 Million - $7.83 Million	182,091 Added 88.26%	388,395 $14.6 Million
Q2 2020 Aug 14, 2020	SELL	$37.87 - $43.58 $269,634 - $310,289	-7,120 Reduced 3.34%	206,304 $8.42 Million
Q1 2020 May 15, 2020	BUY	$32.47 - $48.83 $252,843 - $380,239	7,787 Added 3.79%	213,424 $8.09 Million
Q4 2019 Feb 13, 2020	SELL	$42.0 - $48.25 $4.9 Million - $5.63 Million	-116,735 Reduced 36.21%	205,637 $9.66 Million
Q3 2019 Nov 14, 2019	SELL	$40.46 - $43.52 $501,380 - $539,299	-12,392 Reduced 3.7%	322,372 $13.8 Million
Q2 2019 Aug 14, 2019	BUY	$39.4 - $42.7 $980,469 - $1.06 Million	24,885 Added 8.03%	334,764 $13.4 Million
Q1 2019 Jun 12, 2019	SELL	$38.57 - $42.69 $75,982 - $84,099	-1,970 Reduced 0.63%	309,879 $13 Million
Q1 2019 May 10, 2019	BUY	$38.57 - $42.69 $522,237 - $578,022	13,540 Added 4.54%	311,849 $13 Million
Q4 2018 Feb 06, 2019	SELL	$37.8 - $42.69 $1.72 Million - $1.95 Million	-45,589 Reduced 13.26%	298,309 $11.4 Million
Q3 2018 Nov 13, 2018	SELL	$39.75 - $42.69 $161,742 - $173,705	-4,069 Reduced 1.17%	343,898 $13.8 Million
Q2 2018 Aug 13, 2018	SELL	$39.61 - $42.76 $4.06 Million - $4.39 Million	-102,599 Reduced 22.77%	347,967 $14 Million
Q1 2018 May 09, 2018	BUY	$36.18 - $40.15 $2.94 Million - $3.26 Million	81,269 Added 22.01%	450,566 $17.6 Million
Q4 2017 Feb 12, 2018	SELL	$35.34 - $41.9 $1.84 Million - $2.18 Million	-52,027 Reduced 12.35%	369,297 $13.1 Million
Q3 2017 Nov 07, 2017	BUY	$39.44 - $41.55 $16.6 Million - $17.5 Million	421,324	421,324 $17.1 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Account